User Experience Performance Global Diagnostic Results

Webpage: https://indofarma.id

Device: Desktop Computer

Region: Global (total 6 regions)

Indofarma's Global Reach Limited by 41% Performance Score in Asia Pacific Markets

Critical website speed issues detected across key pharmaceutical markets. Sydney tests reveal performance scores 48% below industry standards, potentially impacting international drug distribution and healthcare accessibility.

Test Your Global Performance on PulseDX

Average Score

41
Average Page Performance is Poor
Click on the country to view detailed metrics for each region
Australia (Sydney)
41 / 100
Poor Performance
United States East (Virginia)
Website Refused Access or No Response
Japan (Tokyo)
Website Refused Access or No Response
Ireland (Dublin)
Website Refused Access or No Response
Germany (Frankfurt)
Website Refused Access or No Response
United States West (Oregon)
Website Refused Access or No Response

PT Indofarma's International Healthcare Access Hindered by 89% Speed Gap

Your pharmaceutical platform shows concerning performance metrics in Sydney, with connectivity issues across 5 major global regions. This affects your ability to serve international healthcare providers and patients effectively.

Analyze Your Site Now on PulseDX